Extensive clinical experience with Taxotere® (T) is 1st and 2nd line treatment (tt) at 100 mg/m2 in locally advanced (LA) or metastatic breast cancer (MBC)

Autor:	D. Hess, H. Wilke, K.S. Khoo, S. Cabral, E. Joosens, L. Orlandi, H. Köhne, H. Reksodiputro, S. Gozdz, B. Boussard
Rok vydání:	1999
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Internal medicine medicine Locally advanced Line (text file) medicine.disease business Metastatic breast cancer
Zdroj:	European Journal of Cancer. 35:S320
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(99)81699-2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::58db6d56bf47ba25006383a4c5b3470c https://doi.org/10.1016/s0959-8049(99)81699-2 Zobrazit plný text záznamu Full Text from ScienceDirect